SNCA and Parkinson disease: Four studies including 271 PD patients and 205 controls found a significant increase in the mean difference of oligomeric salivary alpha‐synuclein among PD patients as compared to healthy controls [SMD (Hedges' g) = 2.88, 95% CI: 0.59–5.16, p‐value = <0.001).